Related Experiment Video
Updated: Aug 11, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Longitudinal evaluation of pulmonary function in infants and very young children with cystic fibrosis
R S Tepper1, G L Montgomery, V Ackerman
1Department of Pediatrics, Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis 46202-5225.
Insights
Infants diagnosed with cystic fibrosis (CF) and respiratory symptoms show persistently lower pulmonary function one year later. Early detection of respiratory symptoms in CF infants is crucial for predicting long-term lung health.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Cystic Fibrosis Research
Background:
- Cystic Fibrosis (CF) diagnosis in infancy requires understanding early lung function.
- Pulmonary function and radiographic changes in infants with CF are not fully characterized at diagnosis and during early follow-up.
Purpose of the Study:
- To assess pulmonary function and chest radiographic changes in infants with CF at diagnosis and one year later.
- To identify predictors of lung function decline in infants with CF.
Main Methods:
- Pulmonary function testing (PFT) and chest radiographs were performed on 32 infants with CF at diagnosis and at a 1-year follow-up.
- Infants were categorized into those with (RESP) and without (NRESP) respiratory symptoms at diagnosis.
Main Results:
- At diagnosis, infants in the RESP group had significantly lower maximal expiratory flows at functional residual capacity (Vmax FRC) compared to the NRESP group.
- While Vmax FRC improved in the RESP group over one year, it remained significantly lower than in the NRESP group at follow-up.
- Lower Vmax FRC at diagnosis correlated with lower Vmax FRC at the 1-year follow-up, indicating persistent functional deficits.
Conclusions:
- Infants with CF presenting with respiratory symptoms at diagnosis experience persistent deficits in lung function one year later, despite some improvement.
- Early pulmonary function, particularly Vmax FRC, at the time of CF diagnosis is a significant predictor of lung function at one year.
Abstract:
Thirty-two infants with cystic fibrosis (CF) had pulmonary function testing and chest radiographs at the time of diagnosis and on average 1 year later, when they had no acute respiratory symptoms. At diagnosis, 14 of 32 infants had respiratory symptoms (RESP) and 18 did not have respiratory symptoms (NRESP). There were no significant differences in age, weight, or length between the RESP and NRESP groups. At diagnosis, the RESP group had significantly lower forced expiratory flows compared to the NRESP group (41 +/- 32% vs. 98 +/- 48% predicted); however, there were no significant differences in functional residual capacity or chest radiographic scores. Between diagnosis and follow-up, the NRESP group had no significant change in pulmonary function but a decline in chest roentgenographic (CXR) scores (22 +/- 2 to 21 +/- 2). For infants in the RESP group, there were no significant changes in FRC or CXR score. Maximal expiratory flow at functional residual capacity (Vmax FRC) rose from diagnosis to 1 year follow-up (41 +/- 32% to 74 +/- 27% predicted; P < 0.002); however, at follow-up flows for the RESP group remained significantly lower than flows for the NRESP group (74% vs. 113% predicted; P < 0.0005). For the 32 infants with CF, there was significant correlation between percent predicted Vmax FRC at follow-up and at diagnosis (r = 0.47; P < 0.02). Those infants with lower percent predicted flows at diagnosis were more likely to have lower percent predicted flows 1 year later.(ABSTRACT TRUNCATED AT 250 WORDS)
More Related Videos
Related Concept Videos
Longitudinal Research
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...

